Browsing by Author Friedlander, Michael L.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)Citation
2011Early Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer.Brown, Christopher; Gebski, Val; Lee, Chee; Lord, Sarah (Sally); Simes, Robert John; Delva, Remy; Donadello, Nicoletta; Friedlander, Michael L.; Georgoulopoulos, Alexander; Mirza, Mansoor Raza; Pignata, Sandro; Pujade-Lauraine, Eric; Schmalfeldt, Barbara; Southier, Philippe; Vergote, Ignace; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEarly Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer., Journal of the National Cancer Institute, vol.103, 17, 2011,pp 1338-1342
2013Feasibility, acceptability and preferences for intraperitoneal chemotherapy with paclitaxel and cisplatin after optimal debulking surgery for ovarian and related cancers: an ANZGOG studyBrand, Alison; Donohue, Mark; Gainford, Corona; Gebski, Val; Martyn, Julie; Stockler, Martin; Blinman, Prunella L; Bloomfield, Penny; Friedlander, Michael L.; Grant, Peter Thomas; Kichenadasse, G; Shannon, Catherine; Vaughan, Michelle; Western Clinical School: Medicine (Westmead); Linguistics; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreFeasibility, acceptability and preferences for intraperitoneal chemotherapy with paclitaxel and cisplatin after optimal debulking surgery for ovarian and related cancers: an ANZGOG study, Journal of Gynecologic Oncology, vol.24, 4, 2013,pp 359-366
2011IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell CancerdeFazio, Anna; Anglesio, Michael S.; Australian Ovarian Cancer Study Group, (AOCSG); Balkwill, Frances; Birrer, Michael J.; Bowtell, David D L; Campbell, Ian G.; Chakravarty, Probir; Coward, Jermaine; Cowin, Prue; Friedlander, Michael L.; George, Joshy; Gilks, B; Gorringe, Kylie; House, Colin; Huntsman, David; Kalloger, Steve; Kulbe, Hagen; Lemech, Charlotte; Okamoto, Aikou; Power, Jeremy; Rischin, D.; Western Clinical School: Westmead Millennium InstituteIL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer, Clinical Cancer Research, vol.17, 8, 2011,pp 2538-2548
2008The impact of aromatase inhibitors on sexual functioning: Current knowledge and future research directionsJuraskova, Ilona; Friedlander, Michael L.; Mok, Kelly; PsychologyThe impact of aromatase inhibitors on sexual functioning: Current knowledge and future research directions, The Breast Journal 2005, vol.17,(N/A),2008,pp 436-440
2012Making hard choices easier: A prospective, multicentre study to assess the efficacy of a fertility-related decision aid in young women with early-stage breast cancerButow, Phyllis; Thewes, Belinda; Cheah, Benjamin; Friedlander, Michael L.; Hart, Roger; Hickey, Martha; Meiser, Bettina; Peate, Michelle; Phillips, Kelly-Anne; Saunders, Christobel; Psychology; PsychologyMaking hard choices easier: A prospective, multicentre study to assess the efficacy of a fertility-related decision aid in young women with early-stage breast cancer, British Journal of Cancer, vol.106, 6, 2012,pp 1053-1061
2005Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohortButow, Phyllis; Price, Melanie; Chang, Jiun-Horng; Friedlander, Michael L.; Hopper, John L.; Lindeman, Geoffrey J; McKay, Michael J.; McLachlan, Sue Anne; Phillips, Kelly-Anne; Stewart, Ailsa E; Weideman, Prue C; Psychology; PsychologyPredictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort, Familial Cancer, vol.4,(2),2005,pp 105-113
2002Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective studyButow, Phyllis; Meiser, Bettina; Clifton, M; Friedlander, Michael L.; Thewes, Belinda; Tiller, K; Tucker, K; Psychology; Northern Clinical School: Psychological MedicinePsychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective study, Gynecologic oncology, vol.86, 2,pp 212-219